Brain scan Tune-Up: healthy volunteers help researchers recalibrate MRI machines
NCT ID NCT07453108
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study involves 40 healthy volunteers aged 18 to 86 who will undergo MRI brain scans and transcranial magnetic stimulation (TMS). The goal is to collect reference data to recalibrate the hospital's MRI scanner after an upgrade. No treatment or drug is being tested; the results will support future research on neuropsychiatric disorders.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2023
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 86 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Men or women aged 18 to 86 inclusive; * Affiliated to a social health insurance scheme * Able to understand the objectives and risks of the research and to give dated and signed informed consent; * B2 or above level of French language according to the European Framework of Reference for Languages; * No personal or family psychiatric history of endogenous psychosis, including substance abuse (excluding moderate tobacco, alcohol and caffeine use); * No chronic pathology requiring treatment (mainly diabetes, hypertension, hyperlipidemia or cholesterolemia); * Matched on age, gender and education level of the patients included in our different studies * Woman of childbearing age: negative urine pregnancy test at the inclusion visit and effective contraception throughout the study (intrauterine device, sterilisation, oestrogen or progestin per os, injectable or as an implant or ring). Exclusion Criteria: * Contraindication to MRI or rTMS: presence of a non-removable ferromagnetic foreign body, prosthesis, pacemaker, medication delivered by an implanted pump, vascular clip or stent, heart valve or ventricular bypass, epilepsy; * History that may affect brain anatomy or be related to an abnormality (neurosurgery, epilepsy, stroke, head injury with loss of consciousness for more than 15 minutes and mental retardation - Intelligence Quotient (IQ) \< 70 on the fNART); * History of potentially affecting brain function (general anaesthesia or Electroconvulsive Therapy (ECT) \< 3 months prior to inclusion); * Breastfeeding women ; * Pregnant women ; * Serious or unstabilised somatic pathology ; * Chronic intake of a treatment related to an ongoing disease; * Deprived of liberty, in forced care or under legal protection ; * Under guardianship or curatorship ; * Emergency or life-threatening situation) ; * Exclusion period (determined by a previous or current study).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Neuropsychiatric disorders are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Les Hôpitaux Universitaires
Strasbourg, Bas-Rhin, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.